|Articles|January 19, 2016
BioClinica Acquires Clinverse
The acquisition adds Clinverse’s automated financial management technology solutions to Bioclinica’s portfolio of solutions.
Advertisement
BioClinica clinical trials services and technology provider, announced that it has acquired Clinverse. The acquisition adds Clinverse’s automated financial management technology solutions to Bioclinica’s portfolio of solutions and services. Clinverse becomes a part of BioClinica’s eHealth Solutions business segment.
Read the full
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
2
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
3
ACT Brief: Enterprise Risk Management, Execution Architecture for AI, and Rare Pediatric Regulatory Support
4
ACT Brief: Data Pipeline Fragmentation, Vaccine Trial Pressures, and BTK Degrader Partnership
5